Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.31 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
| ▸ | NOS3 | P29474 | 2/20 | 0.31 |
| ▸ | NOS1 | P29475 | 2/20 | 0.31 |
| ▸ | NOS2 | P35228 | 2/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CCR5 | P51681 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15105217 | 0.87 | TSHR (0.36) | TSHRLMNAGPR84ESR1 | |
| SCHEMBL9734906 | 0.84 | TSHR (0.48) | TSHRLMNAGPR84GABRA1GABRB2 | |
| SCHEMBL9188305 | 0.80 | NR1I2 (0.43) | — | |
| SCHEMBL944816 | 0.80 | TSHR (0.64) | TSHRLMNAGABRA1GABRB2 | |
| SCHEMBL29034985 | 0.80 | GPR84 (0.44) | TSHRLMNAGPR84TP53MAPT | |
| Hydrochloric Acid SCHEMBL3838835 | 0.79 | NR1I2 (0.42) | — | |
| SCHEMBL11162216 | 0.78 | CYSLTR2 (0.43) | TSHRLMNATP53MAPTHDAC8 | |
| SCHEMBL3672924 | 0.76 | TSHR (0.39) | TSHRLMNA | |
| SCHEMBL10455676 | 0.76 | TSHR (0.39) | TSHRLMNA | |
| SCHEMBL28221722 | 0.76 | LMNA (0.52) | TSHRLMNAGABRA1GABRB2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113929866-B | Modified resin and resin composition | 旭化成株式会社 | 2023-07-07 | — | — | CN | disclosed |
| CN-111205424-B | Modified resin and resin composition | 旭化成株式会社 | 2022-04-08 | — | — | CN | disclosed |
| CN-113929866-A | Modified resin and resin composition | 旭化成株式会社 | 2022-01-14 | — | — | CN | disclosed |
| US-11192853-B2 | Separation method and method for producing isocyanate | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2021-12-07 | — | — | US | disclosed |
| CN-107629183-B | Modified resin and resin composition | 旭化成株式会社 | 2021-01-05 | — | — | CN | disclosed |
| EP-2641896-B1 | SEPARATION METHOD | ASAHI CHEMICAL IND (JP) | 2020-10-14 | — | — | EP | disclosed |
| CN-111205424-A | Modified resin and resin composition | 旭化成株式会社 | 2020-05-29 | — | — | CN | disclosed |
| EP-2626345-B1 | SEPARATION METHOD AND METHOD FOR PRODUCING ISOCYANATE | ASAHI CHEMICAL IND (JP) | 2019-01-16 | — | — | EP | disclosed |
| US-9950273-B2 | Method of separation | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2018-04-24 | — | — | US | disclosed |
| US-20180105489-A1 | Separation Method and Method for Producing Isocyanate | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2018-04-19 | — | — | US | disclosed |
| US-9884810-B2 | Separation method and method for producing isocyanate | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2018-02-06 | — | — | US | disclosed |
| US-20140332367-A1 | Method of Separation | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2014-11-13 | — | — | US | disclosed |
| EP-2641896-A1 | SEPARATION METHOD | Asahi Kasei Chemicals Corporation (JP) | 2013-09-25 | — | — | EP | disclosed |
| EP-2626345-A1 | SEPARATION METHOD AND METHOD FOR PRODUCING ISOCYANATE | Asahi Kasei Chemicals Corporation (JP) | 2013-08-14 | — | — | EP | disclosed |
| US-20130184488-A1 | Separation Method and Method for Producing Isocyanate | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2013-07-18 | — | — | US | disclosed |
| EP-0896050-A1 | Lubricating oil composition comprising a specific base oil and an oxidation inhibitor | NIPPON OIL CO., LTD. (JP) | 1999-02-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140332367-A1 | Method of Separation | CCKBR, MAOB, CA9 | TSHR 3686/4885LMNA 1877/4885GPR84 2889/4885 |
| US-11192853-B2 | Separation method and method for producing isocyanate | IDH3A, IDH3B, CA9 | TSHR 4739/4885LMNA 1338/4885GPR84 4361/4885 |
| US-20130184488-A1 | Separation Method and Method for Producing Isocyanate | IDH3A, IDH3B, CA9 | TSHR 4739/4885LMNA 1338/4885GPR84 4361/4885 |
| US-20180105489-A1 | Separation Method and Method for Producing Isocyanate | IDH3A, IDH3B, CA9 | TSHR 4739/4885LMNA 1338/4885GPR84 4361/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.